COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1686: Articles 16851-16860  | Next

Effectiveness of a telerehabilitation program for COVID-19 survivors (TERECO) on exercise capacity, pulmonary function, lower limb muscle strength, and quality of life: a randomised controlled trial
Li, J., Xia, W., Zhan, C., Liu, S., Yin, Z., Wang, J., Chong, Y., Zheng, C., Fang, X., Cheng, W., Reinhardt, J. D.
10.1101/2021.03.08.21253007 — Posted: 2021-03-09
A quantitative risk estimation platform for indoor aerosol transmission of COVID-19
Parhizkar, H., Van Den Wymelenberg, K., Haas, C., Corsi, R.
10.1101/2021.03.05.21252990 — Posted: 2021-03-09
Categorizing the Status of COVID-19 Outbreaks Around the World
Callan, J. P., Nouwen, C. J. A., Lexmond, A. S., Fourtassi, O.
10.1101/2021.03.08.21252586 — Posted: 2021-03-09
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
Abu-Raddad, L. J., Dargham, S., Chemaitelly, H., Coyle, P. J., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., YASSINE, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.03.06.21252601 — Posted: 2021-03-09
COVID-19 vaccine distrust in Colombian university students: Frequency and associated variables
Campo-Arias, A., Pedrozo-Pupo, J. C.
10.1101/2021.03.07.21253080 — Posted: 2021-03-09
Early estimates of SARS-CoV-2 B.1.1.7 variant emergence in a university setting
Johnson, K. E., Woody, S., Lachmann, M., Fox, S. J., Klima, J., Hines, T. S., Meyers, L. A.
10.1101/2021.03.05.21252541 — Posted: 2021-03-09
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Deng, X., Garcia-Knight, M. A., Khalid, M. M., Servellita, V., Wang, C., Morris, M. K., Sotomayor-Gonzalez, A., Glasner, D. R., Reyes, K. R., Gliwa, A. S., Reddy, N. P., Sanchez San Martin, C., Federman, S., Cheng, J., Balcerek, J., Taylor, J., Streithorst, J. A., Miller, S., Kumar, G. R., Sreekumar, B., Chen, P.-Y., Schulze-Gahmen, U., Taha, T. Y., Hayashi, J. M., Siomoneau, C. R., McMahon, S., Lidsky, P. V., Xiao, Y., Green, N. M., Hemarajata, P., Espinosa, A., Kath, C., Haw, M., Bell, J., Hacker, J. K., Hanson, C., Wadford, D. A., Anaya, C., Ferguson, D., Lareau, L. F., Frankino, P. A., Shivram, H., Wyman, S. K., Ott, M., Andino, R., Chiu, C. Y.
10.1101/2021.03.07.21252647 — Posted: 2021-03-09
Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-throughput Drive-through Community Testing Site in Massachusetts
Pollock, N. R., Tran, K., Jacobs, J. R., Cranston, A. E., Smith, S., O'Kane, C. Y., Roady, T. J., Moran, A., Scarry, A., Carroll, M., Volinsky, L., Perez, G., Patel, P., Gabriel, S., Lennon, N. J., Madoff, L. C., Brown, C., Smole, S. C.
10.1101/2021.03.07.21253101 — Posted: 2021-03-09
COVID-19-associated school closures and related efforts to sustain education and subsidized meal programs, United States, February 18-June 30, 2020
Zviedrite, N., Hodis, J. D., Jahan, F., Gao, H., Uzicanin, A.
10.1101/2021.03.05.21252848 — Posted: 2021-03-09
A Comparative Analysis of Clinical Stage 3 COVID-19 Vaccines using Knowledge Representation
Burgos-Salcedo, J. D.
10.1101/2021.03.07.21253082 — Posted: 2021-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).